INSM

2024Q4BMO

Insmed Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-02-20 · Fiscal end 2024-12-31 · Features as of 2025-02-19

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-1.23
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move4.7%
IV front—
P/C full—
P/C front—
Features as of2025-02-19

Run-up

Close—
Ret 5d+4.9%
Ret 10d+3.5%
Ret 20d+9.2%
Ret 30d+20.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-1.32Miss
Estimated EPS-1.23
Actual revenue
104.4M
Surprise %-7.3%
Beat / missMiss
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction+4.4%
Implied vs actual

Implied 4.7%Actual 4.4%

Gap reaction-4.4%
Day result-0.3%
Next-day upYes
Realized / IV0.95×

Post tape

Post 5d-5.5%
Post 10d-10.3%
Post volume2.3M
Vol ×10d1.27×
Vol ×20d1.31×
Post range6.0%